MEDISAFE 1 TECHNOLOGIES CORP. INVESTMENT AGREEMENTInvestment Agreement • April 18th, 2011 • Medisafe 1 Technologies Corp • Surgical & medical instruments & apparatus • Georgia
THIS INVESTMENT AGREEMENT DOES NOT CONSTITUTE AN OFFER TO SELL, OR A SOLICITATION OF AN OFFER TO PURCHASE, ANY OF THE SECURITIES DESCRIBED HEREIN BY OR TO ANY PERSON IN ANY JURISDICTION IN WHICH SUCH OFFER OR SOLICITATION WOULD BE UNLAWFUL. THESE SECURITIES HAVE NOT BEEN RECOMMENDED BY ANY FEDERAL OR STATE SECURITIES AUTHORITIES, NOR HAVE SUCH AUTHORITIES CONFIRMED THE ACCURACY OR DETERMINED THE ADEQUACY OF THIS DOCUMENT. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 18th, 2011 • Medisafe 1 Technologies Corp • Surgical & medical instruments & apparatus • Georgia
This Registration Rights Agreement (this "Agreement"), dated as of April 13, 2011, by and between Medisafe 1 Technologies Corp., a Delaware corporation (the "Company"), and Centurion Private Equity, LLC, a limited liability company organized under the laws of the state of Delaware (”Investor” or the “Holder”).
BETWEEN MEDISAFE 1 TECHNOLOGIES CORP., AS LICENSOR AND SAFECODE DRUG TECHNOLOGIES CORP., AS Licensee Dated: November 15, 2012 LICENSE AGREEMENTLicense Agreement • May 1st, 2013 • Medisafe 1 Technologies Corp • Surgical & medical instruments & apparatus • New York
This License Agreement, dated this 15 day of November, 2012 (the "License Agreement"), is by and between Medisafe 1 Technologies Corp., a Delaware corporation having its principal office at 5a Hataltan Street, Jerusalem 96926, Israel (hereinafter, the "Licensor”) and Safecode Drug Technologies Corp., a Delaware corporation having its principal office at 6 Meever HaMiltah Street, Jerusalem 97761, Israel (hereinafter, the "Licensee”). The Licensor and Licensee are sometimes referred to individually, as a "Party" and collectively, as the "Parties."
Subscription Agreement Medisafe 1 Technologies CorpSubscription Agreement • February 23rd, 2010 • Medisafe 1 Technologies Corp • Surgical & medical instruments & apparatus
100,000 shares of Common Stock ($.0001par value) (the “Common Stock”) of The Medisafe 1 Technologies Corp ( the “Company”) at $0.025 per Share pursuant to receiving a copy of the registration statement filed under Form S1 of the Securities Act of 1933, as amended (the “Act”) and the prospectus contained therein, the undersigned acknowledges that he fully understands that (i) the Company is a start-up company and has not yet generated revenue; (ii) following completion of its current financing (assuming 4,000,000 shares are sold), the Company will have 10,000,000 shares of Common Stock issued and outstanding; and (iii) the Shares are being offered pursuant to registration under Form S1 of the Securities Act of 1933, as amended (the “Act”) and the prospectus contained therein. It is further acknowledged that the Undersigned: (i) has received a copy of the prospectus (hardcopy or electronically); (ii) is not relying upon any representations other than those contained in the prospectus; an
PROJECT AGREEMENT Parties to the agreement ("Agreement"), dated July 6th 2010 By Medisafe 1 Technologies Corp, a corporation registered in the State of Delaware, having its offices at 5 Hataltan Street Jerusalem , IsraelProject Agreement • May 9th, 2011 • Medisafe 1 Technologies Corp • Surgical & medical instruments & apparatus
1MediSafe wishes to engage MM to design and develop a working model on the basis of US Patent #7,347,841 titled “Protector for Administering Medicine” (hereinafter: the "Services" and/or the "Product").
Subscription Agreement Medisafe 1 Technologies CorpSubscription Agreement • May 9th, 2011 • Medisafe 1 Technologies Corp • Surgical & medical instruments & apparatus
100,000 shares of Common Stock ($.0001par value) (the “Common Stock”) of The Medisafe 1 Technologies Corp (the “Company”) at $0.025 per Share pursuant to receiving a copy of the registration statement filed under Form S1 of the Securities Act of 1933, as amended (the “Act”) and the prospectus contained therein, the undersigned acknowledges that he fully understands that (i) the Company is a start-up company and has not yet generated revenue; (ii) following completion of its current financing (assuming 4,000,000 shares are sold), the Company will have 10,000,000 shares of Common Stock issued and outstanding; and (iii) the Shares are being offered pursuant to registration under Form S1 of the Securities Act of 1933, as amended (the “Act”) and the prospectus contained therein. It is further acknowledged that the Undersigned: (i) has received a copy of the prospectus (hardcopy or electronically); (ii) is not relying upon any representations other than those contained in the prospectus; and
CONSULTING AGREEMENTConsulting Agreement • June 13th, 2011 • Medisafe 1 Technologies Corp • Surgical & medical instruments & apparatus • Delaware
This CONSULTING AGREEMENT (this “Agreement”), dated as of April 11, 2011, is by and between Medisafe 1 Technologies, Inc. a Delaware corporation (the “Company”), and Asher Zwebner, an individual residing at (“Consultant”).
